Genetical therapy

Europe Precision Diagnostics Market Report 2022: The Era of Personalized Medicine is Dawning, Fueling Industry Growth

Global Regenerative Medicine Market Report 2022: 3M, Allergan, Medtronic, Smith & Nephew, Stryker, Novartis, etc.

Dublin, Jan. 13, 2023 (GLOBE NEWSWIRE) — The “regenerative medicine market by product (cell therapy (autologous, allogeneic), gene therapy, tissue engineering (scaffolding, hydrogels), application (musculoskeletal, oncology, cardiovascular , ophthalmology, Wound Care), Region – Global Forecast to 2027” report has been added to from ResearchAndMarkets.com offer. The regenerative medicine market is expected to reach USD 40.6 …

Global Regenerative Medicine Market Report 2022: 3M, Allergan, Medtronic, Smith & Nephew, Stryker, Novartis, etc. Read More »

Cassidy could change the way America pays for expensive gene therapies

Cassidy could change the way America pays for expensive gene therapies

Senator Bill Cassidy is set to become a Ranking Member of HELP the same year a gene therapy for sickle cell disease is expected to hit the market. Interestingly, he has written extensively about policy changes that could help the healthcare system absorb this multi-million dollar class of drugs. Why is this important: Congress hasn’t …

Cassidy could change the way America pays for expensive gene therapies Read More »

A new family of adeno-associated viral vectors has been shown to be more efficient in delivering genetic cargo

A new family of adeno-associated viral vectors has been shown to be more efficient in delivering genetic cargo

Gene therapies can treat and even cure some genetic diseases, but it is difficult to deliver the treatments to the parts of the body where they are needed. The researchers engineered viruses called adeno-associated viruses (AAV) to deliver the cargo -; as a functional copy of a gene -; to specific cells and organs, but …

A new family of adeno-associated viral vectors has been shown to be more efficient in delivering genetic cargo Read More »

The psychedelic drug "magic mushroom" can relieve some depression

Death in CRISPR gene therapy study sparks search for answers

The only volunteer in a unique study involving a gene-editing technique has died, and those behind the trial are now trying to figure out what killed him. Terry Horgan, a 27-year-old man with Duchenne muscular dystrophy, died last month, according to Cure Rare Disease, a Connecticut-based nonprofit founded by his brother, Rich, to try to …

Death in CRISPR gene therapy study sparks search for answers Read More »